Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Sep;27(9):1759-71.
doi: 10.1007/s11095-010-0141-7. Epub 2010 Jul 1.

Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis

Hu Yang  1
Affiliations
Review

Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis

Hu Yang. Pharm Res. 2010 Sep.

Abstract

Central nervous system (CNS) diseases represent the largest and fastest-growing area of unmet medical need. Nanotechnology plays a unique instrumental role in the revolutionary development of brain-specific drug delivery, imaging, and diagnosis. With the aid of nanoparticles of high specificity and multifunctionality, such as dendrimers and quantum dots, therapeutics, imaging agents, and diagnostic molecules can be delivered to the brain across the blood-brain barrier (BBB), enabling considerable progress in the understanding, diagnosis, and treatment of CNS diseases. Nanoparticles used in the CNS for drug delivery, imaging, and diagnosis are reviewed, as well as their administration routes, toxicity, and routes to cross the BBB. Future directions and major challenges are outlined.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustration of typical nanoparticles used in brain-specific drug delivery, imaging, and diagnosis.
Figure 2
Figure 2
The main routes for transport of substances across the BBB. a) paracellular aqueous pathway, b) transcellular lipophilic pathway, c) transport proteins, d) receptor-mediated transcytosis, and e) adsorptive-mediated transcytosis.
See this image and copyright information in PMC

References

    1. Johnson N, Davis T, Bosanquet N. The epidemic of Alzheimer's disease. How can we manage the costs? Pharmacoeconomics. 2000;18:215–23. - PubMed
    1. Pardridge WM. Blood-brain barrier biology and methodology. J Neurovirol. 1999;5:556–69. - PubMed
    1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41–53. - PubMed
    1. Smith QR, Rapoport SI. Cerebrovascular permeability coefficients to sodium, potassium, and chloride. J Neurochem. 1986;46:1732–42. - PubMed
    1. Pardridge WM, Buciak JL, Friden PM. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther. 1991;259:66–70. - PubMed

MeSH terms